Dr. Patrick Forde M.D.

Director, Thoracic Oncology Clinical Research Program at Johns Hopkins

Baltimore, MD

How does this work?

Dr. Forde treats patients with lung cancer, mesothelioma and other thoracic cancers. He completed training in internal medicine and oncology in Ireland prior to undertaking a further fellowship at Johns Hopkins. He is currently Associate Member of the Bloomberg~Kimmel Institute for Cancer Immunotherapy and Director of Clinical Research for lung cancer, mesothelioma, and other thoracic cancers at Johns Hopkins. He has led development of a clinical-translational research program focused on the immuno-oncology of upper aerodigestive malignancies. Dr. Forde's research examines the role of immunotherapy for earlier stage lung cancer and his work has led to the development of several ongoing phase 3 trials. He leads international phase 2 and 3 clinical trials of novel immunotherapy approaches for lung cancer and mesothelioma that are currently active in Europe, Asia and North America while also serving as principal investigator for the thoracic cancer immunobiology biospecimen repository at Johns Hopkins.

Ask me about
drug development
Clinical Research IO
Lung and Thoracic Cancers
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Clinical Trials
Work experience

Jan 2019 - Present

Johns Hopkins Hospital

Associate Professor

Oct 2014 - Present

Johns Hopkins Hospital

Lung Cancer Specialist & Assistant Professor of Oncology

Feb 2014 - Sep 2014

Johns Hopkins Hospital

Lung Cancer Specialist & Instructor of Oncology

Jul 2011 - Jan 2014

Johns Hopkins Hospital

Oncology Fellow


Jul 2010 - Jun 2011

St. James's Hospital

Specialist Registrar Oncology


Jul 2009 - Jun 2010

Mercy Hospital

Specialist Registrar Oncology


2011 - 2014

Johns Hopkins University

Fellowship, Oncology

Fellowship in oncology drug development

Board Certified

Talk to Patrick

@ Copyright 2020 OfficeHours Technologies Co.